More on FHTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.3 Score)

Upcoming Events

- Earnings (5/12/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Foghorn Therapeutics Inc. (NQ:FHTX)
Delayed: 5.78 +0.14 (2.48%)
Prev. Close $5.64  
Open$5.45 
52 Wk High$ 
52 Wk Low$ 
Day High$5.83 
Day Low$5.44 
P/E N/A  
EPS$ 
Volume162,000 

Friends, Peers and Foes (?): MRNA, SANA, IQV CRL (more...)

Feb 24, 2026 04:03 PM Form 4 Foghorn Therapeutics For: Feb 23 Filed by: Maynard Ryan D
Feb 24, 2026 04:01 PM Form 3 Foghorn Therapeutics For: Feb 23 Filed by: Maynard Ryan D
Feb 24, 2026 07:00 AM Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences
Feb 23, 2026 07:01 AM Form 8-K Foghorn Therapeutics For: Feb 23
Feb 23, 2026 07:00 AM Foghorn Therapeutics names Ryan Maynard as chief financial officer
Feb 23, 2026 07:00 AM Foghorn Therapeutics Strengthens Financial Leadership with Appointment of Ryan Maynard as Chief Financial Officer
Feb 17, 2026 03:07 AM Jefferies Assumes Foghorn Therapeutics (FHTX) at Buy
Feb 6, 2026 04:01 PM Form 4 Foghorn Therapeutics For: Feb 05 Filed by: GOTTSCHALK ADRIAN
Feb 3, 2026 07:00 AM Foghorn Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit
Feb 2, 2026 04:05 PM Form 4 Foghorn Therapeutics For: Jan 30 Filed by: Costa Carlos
View All Articles

Entities mentioned with FHTX

View All Entities